Allogene Therapeutics, Inc.

NEW YORK STATE COMMON RETIREMENT FUND ALLO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

27,897

Value ($000)

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	38	0.0%	27,897	12/31/2025
2025 Q3	11/3/2025	35	0.0%	27,897	9/30/2025
2025 Q2	10/8/2025	32	0.0%	27,897	6/30/2025
2025 Q1	10/8/2025	41	0.0%	27,897	3/31/2025
2024 Q4	10/8/2025	59	0.0%	27,897	12/31/2024
2024 Q3	10/8/2025	78	0.0%	27,897	9/30/2024
2024 Q2	10/8/2025	65	0.0%	27,897	6/30/2024
2024 Q1	10/8/2025	124	0.0%	27,836	3/31/2024
2023 Q4	10/8/2025	89	0.0%	27,759	12/31/2023
2023 Q3	10/8/2025	89	0.0%	27,946	9/30/2023
2023 Q2	10/8/2025	138	0.0%	27,680	6/30/2023
2023 Q1	10/8/2025	137	0.0%	27,781	3/31/2023
2022 Q4	10/8/2025	360	0.0%	57,197	12/31/2022
2022 Q3	11/8/2022	618	0.0%	57,246	9/30/2022
2022 Q2	8/4/2022	557	0.0%	48,866	6/30/2022
2022 Q1	7/1/2022	446	0.0%	48,988	3/31/2022
2021 Q4	2/2/2022	731	0.0%	48,966	12/31/2021
2021 Q3	11/2/2021	1,263	0.0%	49,137	9/30/2021
2021 Q2	8/2/2021	1,532	0.0%	58,749	6/30/2021
2021 Q1	5/11/2021	1,726	0.0%	48,900	3/31/2021
2020 Q4	2/8/2021	1,234	0.0%	48,900	12/31/2020
2020 Q3	11/5/2020	1,678	0.0%	44,500	9/30/2020
2020 Q2	8/7/2020	1,905	0.0%	44,500	6/30/2020
2020 Q1	5/6/2020	677	0.0%	34,800	3/31/2020
2019 Q4	2/5/2020	904	0.0%	34,800	12/31/2019